C(2022) 5938 final
Versiemijlpaal
Publicatiedatum
22 aug 2022
Ingangsdatum
22 aug 2022
The manufacture of sterile products covers a wide range of sterile product types (active substance, excipient, primary packaging material and finished dosage form), packed sizes (single unit to multiple units), processes (from highly automated systems to manual processes) and technologies (e.g. biotechnology, classical small molecule manufacturing systems and closed systems). This Annex provides general guidance that should be used in the design and control of facilities, equipment, systems and procedures used for the manufacture of all sterile products applying the principles of Quality Risk Management (QRM), to ensure that microbial, particulate and endotoxin/pyrogen contamination is prevented in the final product.
Chronologische releasegeschiedenis
Versiemijlpaal
Publicatiedatum
22 aug 2022
Ingangsdatum
22 aug 2022
We gebruiken cookies om uw ervaring te verbeteren, het gebruik van de website te analyseren en u relevante informatie te tonen. Door alle cookies te accepteren helpt u ons de website beter te maken. Bekijk onze privacyverklaring.
Noodzakelijk
Altijd actief. Nodig om de website goed te laten werken.
Statistieken
Helpt ons de website te verbeteren via anonieme statistieken.
Marketing
Voor marketing- en trackingcookies van derden.